UK health regulator approves up to 7.2 mg weekly dose of Wegovy for obesity patients
- - UK health regulator approves up to 7.2 mg weekly dose of Wegovy for obesity patients
ReutersJanuary 16, 2026 at 2:44 AM
0
FILE PHOTO: Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams/File Photo
Jan 16 (Reuters) - Britain's health regulator approved a maximum dose of up to 7.2 miligrams per week of Novo Nordisk's blockbuster weight-loss drug Wegovy for patients with obesity only, it said on Friday.
(Reporting by Yamini Kalia in Bengaluru; Editing by Sonia Cheema)
Source: “AOL Breaking”
